ai regu
AI Regu, LUMI AI Factory & FAIR EDIH
GenAI & SENSITIVE DATA IN HEALTHCARE
- EVENT SERIES
Generative AI offers significant opportunities for advancing healthcare and health technology. At the same time, organisations must navigate an increasingly complex regulatory landscape, address data protection requirements, establish robust data governance practices, and manage the risks and responsibilities associated with the safe use of AI.
Many stakeholders across the sector are currently grappling with similar questions: What types of data can be used, and under what conditions? How do emerging regulatory requirements affect AI development in practice? How can sensitive data be protected throughout the entire solution lifecycle? And what are the key requirements for the safe deployment and operational use of AI systems?
To address these questions, AI Regu, LUMI AI Factory, and FAIR EDIH are jointly launching a four-part Health Technology Roundtables event series. The series brings together leading experts, practical experiences, and interactive discussions at the intersection of health technology, artificial intelligence, data, and regulation.
- PART 1 | WHAT DOES REGULATION REQUIRE FROM DEVELOPERS? | 26 November 2026
The use of sensitive data in healthcare GenAI development: regulation, legal considerations, and risk assessment - PART 2 | DESIGN AND DEVELOPMENT | TBA
Access to, preparation of, and utilisation of sensitive data in GenAI development - PART 3 | PROTECTING DATA DURING OPERATION | TBA
Protecting sensitive data and managing operational risks in GenAI-enabled solutions - PART 4 | MAINTENANCE AND CONTINUOUS GOVERNANCE | TBA
Monitoring GenAI solutions, change management, and continuous compliance
The AI Regu Health Technology Roundtables are interactive expert forums focusing on current regulatory and practical challenges related to artificial intelligence in the health sector. Expert presentations and facilitated discussions bring together perspectives from regulation, GenAI development, and real-world implementation. Participant questions and insights play a central role in shaping the dialogue.
The events are intended particularly for health technology companies, startups, developers, specialists, and all professionals working at the intersection of AI, data, and regulation.
The workshops are organised as part of the AI Regu Health Technology Roundtables initiative, which aims to support the responsible development of health technology innovations and help organisations navigate an evolving regulatory environment.
UPCOMING EVENTS
The workshop series offers current insights, practical perspectives, and collaborative discussion on the use of generative AI with sensitive data in healthcare. Explore upcoming events and register for the sessions most relevant to your organisation.
26.11.2026 SENSITIVE DATA IN HEALTHCARE | PART 1:
What does regulation require of developers?
Sandra Liede
Leading Expert
Health Technology Sailab – MedTech Finland
Kirsi Talman
Health Tech. and Life Sciences Legal Expert
Laissa Oy
How does regulation affect the development of GenAI systems in healthcare? What legal considerations need to be taken into account when using sensitive data?
AI Regu, LUMI AI Factory and FAIR EDIH are launching a four-part Health Technology Roundtables SHARE event series focusing on the development of GenAI solutions using sensitive data in healthcare. The first event will provide an overview of the regulatory framework affecting GenAI development in healthcare and its implications for practical development work.
TOPICS INCLUDE:
- Key regulatory frameworks relevant to GenAI development in healthcare
- The significance of a GenAI solution’s intended purpose in determining applicable requirements
- Risk classification and risk assessment
- Legal considerations related to the use of sensitive data
- How to incorporate regulatory requirements into the design and development of GenAI solutions
Experts:
Sandra Liede, Leading Expert, Health Technology Sailab – MedTech Finland
Kirsi Talman, Health Tech. and Life Sciences Legal Expert, Laissa Oy
Spaces are limited. Register by 22 November 2026 via the link below!
Please note that the event will be conducted in Finnish.
TBA
SENSITIVE DATA IN HEALTHCARE | Part 2:
Design and Development
Access, Preparation, and Use of Sensitive Data in GenAI Development
TBA
SENSITIVE DATA IN HEALTHCARE | Part 3:
Protecting Data During Operation
Protecting sensitive data and managing operational risks in GenAI-enabled solutions.
TBA
SENSITIVE DATA IN HEALTHCARE | Part 4:
Maintenance and Continuous Governance
Monitoring GenAI solutions, change management, and continuous compliance.